Immunocore Holdings plc·4

Jan 3, 4:08 PM ET

Coy Travis Alan 4

4 · Immunocore Holdings plc · Filed Jan 3, 2025

Insider Transaction Report

Form 4
Period: 2025-01-01
Coy Travis Alan
Chief Financial Officer
Transactions
  • Award

    Employee Share Option (Right to Buy)

    2025-01-01+274,033274,033 total
    Exercise: $29.50Exp: 2034-12-31Ordinary Shares (274,033 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option award shall vest on January 1, 2026, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Documents

1 file
  • 4
    form4-01032025_090124.xmlPrimary